Original Research

Post-marketing surveillance study of the safety and efficacy of nalfurafine hydrochloride (Remitch® capsules 2.5 μg) in 3,762 hemodialysis patients with intractable pruritus

Kozono H, Yoshitani H, Nakano R

International Journal of Nephrology and Renovascular Disease 2018, 11:9-24

Published Date: 15 January 2018